Prions: Health scare and biological challenge

Nature Reviews Molecular Cell Biology

Volumn 2, Issue 2, 2001, Pages 118-126

  Aguzzi, Adriano ^a   Montrasio, Fabio ^a   Kaeser, Pascal S ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINAE;

BRAIN; GENETICS; METABOLISM; PHYSIOLOGY; PRION; PRION DISEASE; REVIEW; SPLEEN;

BRAIN; PRION DISEASES; PRIONS; SPLEEN;

EID: 0035257228     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/35052063     Document Type: Review

References (91)

1. Cohen, C. H. & Valleron, A. J. When did bovine spongiform encephalopathy (BSE) start? Implications on the prediction of a new variant of Creutzfeldt-Jakob disease (nvCJD) epidemic. Int. J. Epidemiol. 28, 526-531 (1999).
2. Anderson, R. M. et al. Transmission dynamics and epidemiology of BSE in British cattle. Nature 382, 779-788 (1996).
3. Ferguson, N. M., Donnelly, C. A., Woolhouse, M. E. & Anderson, R. M. Estimation of the basic reproduction number of BSE: the intensity of transmission in British cattle. Proc. R Soc. Lond B 266, 23-32 (1999).
4. Doherr, M. G., Heim, D., Vandevelde, M. & Fatzer, R. Modelling the expected numbers of preclinical and clinical cases of bovine spongiform encephalopathy in Switzerland. Vet. Rec. 145, 155-160 (1999).
5. Donnelly, C. A., Santos, R., Ramos, M., Galo, A. & Simas, J. P. BSE in Portugal: anticipating the decline of an epidemic. J. Epidemiol. Biostat. 4, 277-283 (1999).
6. Aguzzi, A. & Weissmann, C. Prion research: the next frontiers. Nature 389, 795-798 (1997). Most of the points that were unresolved when this review article was written continue to constitute the next frontiers.
7. Serio, T. R. et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289, 1317-1321 (2000).
8. Sc in vitro.
9. Bessen, R. A. et al. Non-genetic propagation of strainspecific properties of scrapie prion protein Nature 375, 698-700 (1995).
10. Raymond, G. J. et al. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature 388, 285-288 (1997).
11. Telling, G. C. et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83, 79-90 (1995).
12. Peyrin, J. M. et al. Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. Neuroreport 10, 723-729 (1999).
13. Brown, D. R., Schmidt, B. & Kretzschmar, H. A. Role of microglia and host protein in neurotoxicity of a prion protein fragment. Nature 380, 345-347 (1996).
14. Kunz, B., Sandmeier, E. & Christen, P. Neurotoxicity of prion peptide 106-126 not confirmed. FEBS Lett. 458, 65-68 (1999).
15. Büeler, H. R. et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577-582 (1992).
16. Büeler, H. R. et al. Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347 (1993). A 'citation classic', whose title says it all.
17. Sailer, A., Büeler, H., Fischer, M., Aguzzi, A. & Weissmann, C. No propagation of prions in mice devoid of PrP. Cell 77, 967-968 (1994).
18. Brandner, S. et al. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339-343 (1996). The normal prion protein is not only necessary for prion propagation, but also for induction of neurotoxicity.
19. Horiuchi, M. & Caughey, B. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO J. 18, 3193-3203 (1999).
20. Lopez, C. D., Yost, C. S., Prusiner, S. B., Myers, R. M. & Lingappa, V. R. Unusual topogenic sequence directs prion protein biogenesis. Science 248, 226-229 (1990).
21. Yost, C. S., Lopez, C. D., Prusiner, S. B., Myers, R. M. & Lingappa, V. R. Non-hydrophobic extracytoplasmic determinant of stop transfer in the prion protein. Nature 343, 669-672 (1990).
22. Hegde, R. S. et al. A transmembrane form of the prion protein in neurodegenerative disease. Science 279, 827-834 (1998).
23. Hegde, R. S. et al. Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 402, 822-826 (1999).
24. Cashman, N. R. et al. Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell 61, 185-192 (1990).
25. Kitamoto, T., Muramoto, T., Mohri, S., Doh ura, K. & Tateishi, J. Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease. J. Virol. 65, 6292-6295 (1991). This paper showed that FDCs accumulate disease-associated prion protein, and kick-started the whole field of prion neural immunology.
26. Brandner, S., Isenmann, S., Kuhne, G. & Aguzzi, A. Identification of the end stage of scrapie using infected neural grafts. Brain Pathol. 8, 19-27 (1998).
27. Blättler, T. et al. PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature 389, 69-73 (1997).
28. c) is required for scrapie spread within the central nervous system. Proc. Natl Acad. Sci. USA 93, 13148-13151 (1996).
29. Aguzzi, A. Neuro-immune connection in spread of prions in the body? Lancet 349, 742-743 (1997).
30. Fischer, M. et al. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15, 1255-1264 (1996).
31. Race, R., Oldstone, M. & Chesebro, B. Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: role of prion protein expression in peripheral nerves and spleen. J. Virol. 74, 828-833 (2000).
32. Brown, K. L. et al. Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nature Med. 5, 1308-1312 (1999).
33. Klein, M. A. et al. A crucial role for B cells in neuroinvasive scrapie. Nature 390, 687-690 (1997).
34. Manuelidis, L. et al. Follicular dendritic cells and dissemination of Creutzfeldt-Jakob disease. J. Virol. 74, 8614-8622 (2000).
35. Montrasio, F. et al. Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288, 1257-1259 (2000).
36. Mabbott, N. A., Mackay, F., Minns, F. & Bruce, M. E. Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie. Nature Med. 6, 719-720 (2000).
37. Klein, M. A. et al. A role for complement in early prion pathogenesis. (submitted).
38. Klein, M. A. et al. PrP expression in B lymphocytes is not required for prion neuroinvasion. Nature Med. 4, 1429-1433 (1998).
39. Baldauf, E., Beekes, M. & Diringer, H. Evidence for an alternative direct route of access for the scrapie agent to the brain bypassing the spinal cord. J. Gen. Virol. 78, 1187-1197 (1997).
40. Glatzel, M. et al. Adenoviral and adeno-associated viral transfer of genes to the peripheral nervous system. Proc. Natl Acad. Sci. USA 97, 442-447 (2000).
41. c expression in the peripheral nervous system is a determinant of prion neuroinvasion. J. Gen. Virol. 81, 2813-2821 (2000).
42. Collins, S. et al. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 353, 693-697 (1999).
43. Will, R. et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347, 921-925 (1996).
44. Government report on the epidemiology of CJD. http://www.doh.gov.uk/cjd/stats/sept00.htm. (Department of Health, United Kingdom, 2000).
45. Creutzfeldt, H. G. Über eine eigenartige herdförmige Erkrankung des Zentralnervensystems. Z. ges. Neurol. Psychiatr. 57, 1-19 (1920).
46. Jakob, A. Über eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischem Befunde. (Spastische Pseudosklerose-Encephalomyefopathie mit disseminierten Degenerationsherden). Z. ges. Neurol. Psychiatr. 64, 147-228 (1921).
47. Politopoubu, G., Seebach, J. D., Schmugge, M., Schwarz, H. P. & Aguzzi, A. Age-related expression of the cellular prion protein in human peripheral blood leukocytes. Haematologica 85, 580-587 (2000).
48. Zeidler, M. et al. New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet 350, 903-910 (1997).
49. Aguzzi, A. Between cows and monkeys. Nature 381, 734 (1996).
50. Zeidler, M. et al. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 355, 1412-1418 (2000).
51. Hill, A. F., Zeidler, M., Ironside, J. & Collinge, J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 349, 99-100 (1997). A short communication with far-reaching consequences for public health.
52. Hill, A. F. et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353, 183-189 (1999).
53. Collinge, J. Variant Creutzfeldt-Jakob disease. Lancet 354, 317-323 (1999).
54. Palmer, M.S., Dryden, A. J., Hughes, J. T. & Collinge, J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352, 340-342 (1991).
55. Parchi, P. et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol. 46, 224-233 (1999).
56. Fraser, H. & Dickinson, A. G. Distribution of experimentally induced scrapie lesions in the brain. Nature 216, 1310-1311 (1967).
57. Bruce, M. E. et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389, 493-501 (1997).
58. Aguzzi, A. & Weissmann, C. Spongiform encephalopathies: a suspicious signature. Nature 383, 666-667 (1996).
59. Collinge, J., Sidle, K. C., Meads, J., Ironside, J. & Hill, A. F. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383, 685-690 (1996).
60. Hill, A. F. et al. The same prion strain causes vCJD and BSE. Nature 389, 448-450 (1997).
61. Chazot, G. et al. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet 347, 1181 (1995).
62. Lasmézas, C. I. et al. BSE Transmission to Macaques. Nature 381, 743-744 (1996).
63. Sc molecules with different conformations. Nature Med. 4, 1157-1165 (1998).
64. Aguzzi, A. Protein conformation dictates prion strain. Nature Med. 4, 1125-1126 (1998).
65. Ghani, A. C., Donnelly, C. A., Ferguson, N. M. & Anderson, R. M. Assessment of the prevalence of vCJD through testing tonsils and appendices for abnormal prion protein. Proc. R Soc. Lond. B 267, 23-29 (2000).
66. Ghani, A. C., Ferguson, N. M., Donnelly, C. A., Hagenaars, T. J. & Anderson, R M. Estimation of the number of people incubating variant CJD. Lancet 352, 1353-1354 (1998).
67. Race, R. & Chesebro, B. Scrapie infectivity found in resistant species. Nature 392, 770 (1998).
68. Aguzzi, A. & Weissmann, C. Spongiform encephalopathies. The prion's perplexing persistence. Nature 392, 763-764 (1998).
69. Hill, A. F. et al. Species-barrier-independent prion replication in apparently resistant species. Proc. Natl Acad. Sci. USA 97, 10248-10253 (2000).
70. Frigg, R., Klein, M. A., Hegyi, I., Znkernagel, R. M. & Aguzzi, A. Scrapie pathogenesis in subclinically infected B-cell-deficient mice. J. Virol. 73, 9584-9588 (1999).
71. Aguzzi, A. Prion diseases, blood and the immune system: concerns and reality. Haematologica 85, 3-10 (2000).
72. Hilton, D. A., Fathers, E., Edwards, P., Ironside, J. W. & Zajicek, J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 352, 703-704 (1998).
73. Sc detection in the preclinical diagnosis of scrapie. Vet. Rec. 142, 564-568 (1998).
74. Schreuder, B. E., van Keulen, L. J., Smits, M. A., Langeveld, J. P. & Stegeman, J. A. Control of scrapie eventually possible? Vet. Q. 19, 105-113 (1997).
75. Vankeulen, L. J. M. et al. Immunohistochemical detection of prion protein in lytnphoid tissues of sheep with natural scrapie. J. Clin. Microbiol. 34, 1228-1231 (1996).
76. Raeber, A. J. et al. PrP-dependent association of prions with splenic but not circulating lymphocytes of scrapie-infected mice. EMBO J. 18, 2702-2706 (1999).
77. c+ membrane particles in a human T lymphocyte model. J. Immunol. 162, 5712-5718 (1999).
78. Ironside, J. W. et al. Retrospective study of prion-protein accumulation in tonsil and appendix tissues. Lancet 355, 1693-1694 (2000).
79. Fischer, M. B., Roeckl, C., Parizek, P., Schwarz, H. P. & Aguzzi, A. Binding of disease-associated prion protein to plasminogen. Nature 408, 479-483 (2000). Plasminogen seems to be the first endogenous protein that discriminates between normal and pathological prion proteins.
80. Priola, S. A., Raines, A. & Caughey, W. S. Porphyrin and phthalocyanine antiscrapie compounds. Science 287, 1503-1506 (2000).
81. Soto, C. et al. Reversion of prion protein conformational changes by synthetic β-sheet breaker peptides. Lancet 355, 192-197 (2000).
82. Aguzzi, A. & Collinge, J. Post-exposure prophylaxis after accidental prion inoculation. Lancet 350, 1519-1520 (1997).
83. Paushkin, S. V., Kushnirov, V. V., Smimov, V. N. & TerAvanesyan, M. D. In vitro propagation of the prion-like state of yeast Sup35 protein. Science 277, 381-383 (1997).
84. +] factor by in vitro-converted Sup35 protein. Science 289, 595-599 (2000). In this paper, yeast geneticists have achieved what continues to be a Holy Grail for mammalian prion science: de novo generation of recombinant, infectious prions.
85. Taylor, K. L., Cheng, N., Williams, R. W., Steven, A. C. & Wickner, R. B. Prion domain initiation of amyloid formation in vitro from native Ure2p. Science 283, 1339-1343 (1999).
86. Wickner, R. B. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae Science 264, 566-569 (1994). The first suggestion that prions exist in yeast.
87. True, H L. & Lindquist, S. L. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 407, 477-483 (2000).
88. Hope, J. Spongiform encephalopathies. Breech-birth prions. Nature 402, 737-739 (1999).
89. Shmerling, D. et al. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93, 203-214 (1998).
90. Moore, R. C. et al. Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J. Mol. Biol. 292, 797-817 (1999).
91. Endras, R. et al. Mature follicular dendritic cell networks depend on expression of lymphotoxin β receptor by radioresistant stromal cells and of lymphotoxin β and tumor necrosis factor by B cells. J. Exp. Med. 189, 159-167 (1999).